Veterinary drug · Drug monograph
Salbutamol (Albuterol): veterinary dose and monograph
Salbutamol (Albuterol) is a veterinary drug. Short-acting beta-2 adrenergic agonist bronchodilator — the rescue reliever for acute bronchoconstriction in feline asthma and canine/equine lower-airway disease. Indications include acute bronchospasm / asthma crisis (rescue) — feline asthma especially; canine chronic bronchitis with reversible bronchoconstriction; equine recurrent airway obstruction / inflammatory airway disease (bronchodilation). This monograph lists 5 reference doses for dogs, cats and horses, each with route, frequency and source.
At a glance
- Drug class
- Veterinary drug
- Also known as
- Albuterol, Ventolin, Asthalin, Salbutamol sulphate
- Species with doses
- Dogs, Cats and Horses
- Routes
- Inhaled, PO
- Last reviewed
- 1 October 2026
Indications
- Acute bronchospasm / asthma crisis (rescue) — feline asthma especially
- Canine chronic bronchitis with reversible bronchoconstriction
- Equine recurrent airway obstruction / inflammatory airway disease (bronchodilation)
- Pre-treatment before inhaled corticosteroid to improve drug delivery
Salbutamol (Albuterol) dose by species
Doses are per administration unless stated. mg/kg doses scale with body weight; per-animal, per-quarter and infusion-rate doses are shown as the reference writes them.
Dogs
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Bronchodilation (oral) | 0.02–0.05 mg/kg (20–50 µg/kg) PO q8–12h | PO | q8–12h | — |
| Bronchodilation (nebulised) | 0.5 mL of 0.5% solution in 4 mL saline, nebulised q6h (for a ~27 kg dog) | Inhaled | q6h | — |
- Bronchodilation (oral): Plumb’s p.45: 0.05 mg/kg PO q8h (Johnson 2000); 0.02 mg/kg q12h for 5 days, then 0.05 mg/kg q8–12h if needed (Church 2003). Older references citing 50 mg/kg are a gross overdose — ignore. Papich 5e: 20–50 µg/kg q6–8h PO, maximum 100 µg/kg q6h.
- Bronchodilation (nebulised): Plumb’s p.45 (McConnell & Hughey 1992): based on a 60 lb dog. MDI via spacer can also be used.
Cats
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Acute asthma / bronchospasm (rescue, MDI + spacer) | 1 puff (90–100 µg) via spacer and mask as needed; in a crisis every 30 min for 2–4 h | Inhaled | as needed | — |
- Acute asthma / bronchospasm (rescue, MDI + spacer): Plumb’s p.45: one puff as needed with inhaled fluticasone for mild–moderate asthma; severe crisis — oxygen, IV glucocorticoid and one puff every 30 min (Dowling 2003); intermittent signs two puffs twice daily, effect in 5–10 min (Padrid 2006). Reliever, not controller.
Horses
| Indication | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Equine asthma — rescue bronchodilation (inhaled) | 360 µg (4 puffs of a 90 µg MDI) via equine spacer/mask; up to 4 times daily | Inhaled | q4–6h as needed | — |
| Foals — oral bronchodilation | 0.01–0.02 mg/kg PO q8–12h | PO | q8–12h | — |
- Equine asthma — rescue bronchodilation (inhaled): Papich 5e: 360 µg per horse up to four times daily. Plumb’s p.45: 360 µg, repeatable every 15 min for up to 2 h in severe obstruction, then q4–6h (Davis & Rush); 0.8–3 µg/kg by inhalation (Foreman; Lavoie). Tolerance develops if used alone — combine with inhaled corticosteroid. ARCI Class 3.
- Foals — oral bronchodilation: Papich 5e: foals 0.01–0.02 mg/kg q8–12h PO.
Contraindications
Use as sole long-term therapy for inflammatory airway disease (no anti-inflammatory effect; over-reliance signals poor control). Significant tachyarrhythmia, hypertrophic cardiomyopathy/cardiac disease (beta effects), and hypokalaemia. Caution with overuse (the racemic S-enantiomer may worsen airway inflammation with chronic frequent use). Known hypersensitivity.
Species-specific warnings
Cats: Use as rescue only — pair with inhaled corticosteroid (e.g. fluticasone) for control. Over-reliance on salbutamol indicates inadequately treated airway inflammation.
Dogs: A chewed/punctured albuterol inhaler delivers a massive dose — life-threatening tachyarrhythmia and hypokalaemia; treat as an emergency.
Adverse effects
- Tremor, restlessness/agitation
- Tachycardia, arrhythmia
- Hypokalaemia (especially with overuse or systemic dosing)
- Worsening airway inflammation with chronic frequent (racemic) use
- Hyperglycaemia (high systemic doses)
Drug interactions
- Beta-blockers (e.g. propranolol/sotalol): antagonise bronchodilation — avoid in airway patients
- Other sympathomimetics: additive cardiac/tremor effects
- Potassium-lowering drugs (diuretics, corticosteroids): additive hypokalaemia
- Tricyclic/MAOI: potentiated cardiovascular effects
Pregnancy and lactation
Inhaled use gives low systemic exposure and is generally considered acceptable when bronchodilation is needed; high systemic doses can affect uterine tone.
Monitoring
- Respiratory rate/effort and response to the reliever
- Heart rate/rhythm with frequent or systemic use
- Serum potassium with overdose or heavy use
- Frequency of rescue use — escalating need means inadequate anti-inflammatory control
Toxicity and overdose
Overdose (commonly from a dog chewing/puncturing an MDI canister, which releases a large rapid dose) causes marked tachycardia/arrhythmia, severe tremor, agitation, and pronounced HYPOKALAEMIA — a genuine emergency. Systemic overdose mirrors beta-agonist excess.
Management: No specific antidote. Treat hypokalaemia (IV potassium with ECG monitoring) and tachyarrhythmia (a cardioselective beta-blocker, e.g. esmolol/propranolol, cautiously if airway disease allows) — beta-blockade also counters tremor/tachycardia. IV fluids and supportive/monitored care; effects resolve over hours. Inhaler-puncture cases often need overnight ECG/electrolyte monitoring.
Clinical pearls
- It is a RELIEVER, not a controller — every asthmatic cat on salbutamol also needs an inhaled (or systemic) corticosteroid for the underlying inflammation
- Deliver by MDI + spacer + snug mask (e.g. AeroKat-type chamber) for fast, low-side-effect bronchodilation
- Rising rescue-inhaler use is a red flag for poor control — step up anti-inflammatory therapy
- Watch for the classic emergency: a dog that chews an albuterol inhaler — expect tachycardia and dangerous hypokalaemia
- Avoid chronic frequent racemic salbutamol; over-use can paradoxically worsen airway inflammation
Mechanism of action
Selective beta-2 adrenoceptor agonist. Stimulation of beta-2 receptors on airway smooth muscle activates adenylate cyclase, raising intracellular cAMP, which relaxes bronchial smooth muscle and reverses bronchoconstriction within minutes. It also stabilises some mast-cell mediator release. Beta-2 effects elsewhere (skeletal muscle, heart, potassium shift) account for tremor, tachycardia and hypokalaemia.
Formulations and products
- Metered-dose inhaler 100 mcg/puff
- Nebuliser solution 5 mg/mL
- Syrup 2 mg/5 mL (0.4 mg/mL)
- 2 / 4 mg tablet
- Asthalin — 100 mcg/puff MDI; 5 mg/mL respules; 2 mg/5 mL syrup, Inhaler / nebuliser / syrup (human-label)
- Ventolin / Levolin — 100 mcg/puff MDI; 2 / 4 mg tablet, Inhaler / tablet (human-label)
Storage
MDI canisters: 15–30 °C, do not puncture or incinerate (pressurised); keep away from pets that may chew them. Nebuliser solution/syrup/tablets: 15–30 °C, protect from light.
Before you use this dose
Reference doses for veterinary professionals. Confirm the dose against the product label, the patient’s condition, current guidance and local regulations before use; the attending veterinarian remains responsible for every clinical decision.
Frequently asked questions
What is the dose of Salbutamol (Albuterol) for dogs?
Reference doses for Salbutamol (Albuterol) in dogs: 0.02–0.05 mg/kg (20–50 µg/kg) PO q8–12h PO q8–12h (Bronchodilation (oral)); 0.5 mL of 0.5% solution in 4 mL saline, nebulised q6h (for a ~27 kg dog) Inhaled q6h (Bronchodilation (nebulised)). Confirm against the label and the patient before use.
What is the dose of Salbutamol (Albuterol) for cats?
Reference doses for Salbutamol (Albuterol) in cats: 1 puff (90–100 µg) via spacer and mask as needed; in a crisis every 30 min for 2–4 h Inhaled as needed (Acute asthma / bronchospasm (rescue, MDI + spacer)). Confirm against the label and the patient before use.
What is the dose of Salbutamol (Albuterol) for horses?
Reference doses for Salbutamol (Albuterol) in horses: 360 µg (4 puffs of a 90 µg MDI) via equine spacer/mask; up to 4 times daily Inhaled q4–6h as needed (Equine asthma — rescue bronchodilation (inhaled)); 0.01–0.02 mg/kg PO q8–12h PO q8–12h (Foals — oral bronchodilation). Confirm against the label and the patient before use.
When should Salbutamol (Albuterol) not be used?
Use as sole long-term therapy for inflammatory airway disease (no anti-inflammatory effect; over-reliance signals poor control). Significant tachyarrhythmia, hypertrophic cardiomyopathy/cardiac disease (beta effects), and hypokalaemia. Caution with overuse (the racemic S-enantiomer may worsen airway inflammation with chronic frequent use). Known hypersensitivity.
What are the side effects of Salbutamol (Albuterol) in animals?
Tremor, restlessness/agitation; Tachycardia, arrhythmia; Hypokalaemia (especially with overuse or systemic dosing); Worsening airway inflammation with chronic frequent (racemic) use; Hyperglycaemia (high systemic doses).
Sources
- Plumb's Veterinary Drug Handbook
- Merck Veterinary Manual, 11th edition
- Papich, Papich Handbook of Veterinary Drugs, 5th edition
Last reviewed · VetMasterJi